| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/04/1996 | WO1995033049A3 Tbp2 fragments of the transferrine receptor of neisseria meningitidis |
| 01/04/1996 | WO1995029193A3 Melanoma antigens |
| 01/04/1996 | DE4423131A1 Neue hIL-4-Mutantenproteine als Antagonisten oder partielle Agonisten des humanen Interleukin 4 New hIL-4 mutant proteins as antagonists or partial agonists of human interleukin 4 |
| 01/04/1996 | DE4421895A1 Verfahren zur Isolierung von Isolektinen aus der Mistel A method for isolating Isolektinen from mistletoe |
| 01/04/1996 | CA2193832A1 Class bi and ci scavenger receptors |
| 01/04/1996 | CA2170156A1 Protocadherin proteins and their uses |
| 01/03/1996 | EP0690307A1 Method of determining the presence of an autoimmune antibody |
| 01/03/1996 | EP0690132A1 Anti-hiv monoclonal antibody |
| 01/03/1996 | EP0690127A1 Compositions and methods for stimulating megakaryocyte growth and differentiation |
| 01/03/1996 | EP0690071A2 Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase |
| 01/03/1996 | EP0689606A1 ANTIBODIES AND ASSAYS FOR DETERMINING MUTATIONS IN THE $i(APC) GENE |
| 01/03/1996 | EP0689605A1 Hepatitis b escape mutant specific binding molecules |
| 01/03/1996 | EP0689604A1 Process for preparing cancer vaccines |
| 01/03/1996 | EP0689600A1 Process to induce the death of tumor cells |
| 01/03/1996 | EP0689599A1 Chimeric selectin by exchange of domains - uses thereof |
| 01/03/1996 | EP0689597A1 USE OF PORCINE GAL $g(a)(1,3) GALACTOSYL TRANSFERASE IN XENOGRAFT THERAPIES |
| 01/03/1996 | EP0689592A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/03/1996 | EP0689590A1 Totally synthetic affinity reagents |
| 01/03/1996 | EP0689588A1 Extracellular signal-regulated kinase, sequences, and methods of production and use |
| 01/03/1996 | EP0689587A1 Mutant luciferases |
| 01/03/1996 | EP0689552A1 A method of detecting rupture of the amniotic membranes in pregant mammals |
| 01/03/1996 | EP0689551A1 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments |
| 01/03/1996 | EP0689550A1 Novel antimicrobial peptides from bovine neutrophils |
| 01/03/1996 | EP0689547A1 Cloned human alpha1c adrenergic receptor |
| 01/03/1996 | EP0689453A1 High molecular weight surface proteins of non-typeable haemophilus |
| 01/03/1996 | EP0498851B1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 01/03/1996 | EP0478602B1 Expression of tetanus toxin fragment c |
| 01/03/1996 | EP0473701B1 Recombinant dna method for production of parathyroid hormone |
| 01/03/1996 | EP0275300B1 Recombinant vaccine |
| 01/03/1996 | CN1114357A Process for producing recombinative polypeptide using transgene animal |
| 01/03/1996 | CN1114355A DNA amplification |
| 01/02/1996 | US5480972 Diagnosing, treating and preventing sensitivity; dna sequences |
| 01/02/1996 | US5480968 Isolated polypeptide erbB-3, related to the epidermal growth factor receptor and antibody thereto |
| 01/02/1996 | US5480956 Feline interferon and process for production thereof |
| 01/02/1996 | US5480895 Method of producing antibodies to a restricted population of T lymphocytes, antibodies produced therefrom and methods of use thereof |
| 01/02/1996 | US5480864 Modified maxadilan fusion protein containing a thrombin cleavage site; composition for topical application to mammals' skin comprises modified maxadilan protein as vasodilator in vehicle |
| 01/02/1996 | US5480799 Sperm antigen corresponding to a sperm zona binding protein autoantigenic epitope |
| 01/02/1996 | US5480796 Antibodies against the receptor protein for human B cell stimulatory factor-2 |
| 01/02/1996 | US5480795 Curculin B and DNA encoding same, and process for production thereof |
| 01/02/1996 | US5480793 Nucleic acid coding for the human angiotensin converting enzyme (ACE), and its uses, especially for the in vitro diagnosis of arterial hypertension |
| 01/02/1996 | CA2150532A1 Polypeptides |
| 01/02/1996 | CA1337861C De-acyl derivatives of antibiotic a 40926 |
| 12/28/1995 | WO1995035385A1 A FUNGUS WHEREIN THE areA GENE HAS BEEN MODIFIED AND AN areA GENE FROM ASPERGILLUS ORYZAE |
| 12/28/1995 | WO1995035384A1 N-terminally extended proteins expressed in yeast |
| 12/28/1995 | WO1995035380A1 Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
| 12/28/1995 | WO1995035379A1 66 kDa ANTIGEN FROM BORRELIA |
| 12/28/1995 | WO1995035376A2 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains |
| 12/28/1995 | WO1995035375A1 Interleukin-5 specific recombinant antibodies |
| 12/28/1995 | WO1995035374A1 Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 12/28/1995 | WO1995035372A1 5-lipoxygenase-activating protein ii |
| 12/28/1995 | WO1995035368A1 Extraction of heterologous insoluble proteins from bacteria |
| 12/28/1995 | WO1995035317A1 Identification, quantitation and purification of insecticidal proteins from bacillus thuringiensis |
| 12/28/1995 | WO1995035118A1 Contraceptive vaccine |
| 12/28/1995 | WO1995035111A2 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION |
| 12/28/1995 | WO1995033818A3 Genes for the synthesis of antipathogenic substances |
| 12/28/1995 | WO1995028487A3 Recombinant pgp3, methods of preparation and use in diagnosis and therapy |
| 12/28/1995 | WO1995020664A3 Mammalian expression systems for hepatitis c virus envelope genes |
| 12/28/1995 | WO1995016051A3 Methods and compositions for the suppression of neu mediated transformation |
| 12/28/1995 | WO1995015982A3 Process for generating specific antibodies |
| 12/28/1995 | CA2193526A1 Polypeptides with interleukin 8 receptor 1 (il8r1) binding domains |
| 12/28/1995 | CA2193206A1 Contraceptive vaccine |
| 12/28/1995 | CA2192943A1 N-terminally extended proteins expressed in yeast |
| 12/28/1995 | CA2192827A1 Use of .beta.galnac(1-4).beta.gal conjugates to treat candida infection |
| 12/27/1995 | EP0688869A1 Novel osteoinductive compositions |
| 12/27/1995 | EP0688868A1 Genetic detoxification of pertussis toxin |
| 12/27/1995 | EP0688431A1 Method for screening catalytic non-enzyme polypeptides and proteins |
| 12/27/1995 | EP0688363A1 Method of controlling insects in plants |
| 12/27/1995 | EP0688362A1 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 12/27/1995 | EP0688361A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
| 12/27/1995 | EP0688360A1 Bone stimulating factor |
| 12/27/1995 | EP0688338A1 T cell epitopes of ryegrass pollen allergen |
| 12/27/1995 | EP0688334A1 Oligodendroglial trophic factor and methods of use thereof |
| 12/27/1995 | EP0688227A1 Production of human papillomavirus capsid protein and virus-like particles |
| 12/27/1995 | EP0688224A1 A mutant protein and methods and materials for making and using it |
| 12/27/1995 | EP0607178A4 Methods for the selection, separation and fusion of cells. |
| 12/27/1995 | EP0580694A4 Production of phosphopeptides from casein |
| 12/27/1995 | EP0559795B1 Methods for the diagnosis of chronic lower back and cervical pain |
| 12/27/1995 | EP0418230B1 Method for potentiating and inhibiting insulin-like growth factor activity |
| 12/27/1995 | EP0268663B1 Phosphopeptides |
| 12/27/1995 | CN1114112A Bacteriocins from streptococcus thermophilus |
| 12/27/1995 | CN1113954A Producing technology for interleukin-6 |
| 12/27/1995 | CN1030570C Process for preparing 1.5-benzothiazepine derivatives |
| 12/26/1995 | US5478926 Monoclonal antibody against human IgE |
| 12/26/1995 | US5478925 Peptides which block the binding of Tumor Necrosis Factor to its receptors |
| 12/26/1995 | US5478745 Recombinant viral vector system |
| 12/26/1995 | US5478741 Antibodies to the HRPII protein of plasmodium falciparum |
| 12/26/1995 | US5478730 Chemical reactor with barrier for maintaining high molecular weight compounds and replacement of low molecular weight compounds |
| 12/26/1995 | US5478728 Process for antibody combining site-catalyzed SYN elimination in the formation of a CIS olefin |
| 12/26/1995 | US5478725 Contacting endometrium sample with monoclonal antibody specific for integrin, assaying, correlating absence with endometriosis |
| 12/26/1995 | US5478585 Treating with proteolytic or lipolytic enzyme to decompose lipids, extraction with sub or supercritical fluid |
| 12/26/1995 | CA1337841C Antibiotic a 42867 derivative |
| 12/26/1995 | CA1337800C Monoclonal antibody recognizing alpha 2 --> 3 bonds |
| 12/21/1995 | WO1995034817A1 Positive and positive/negative cell selection mediated by peptide release |
| 12/21/1995 | WO1995034668A2 The cytoplasmic inhibition of gene expression |
| 12/21/1995 | WO1995034666A1 Synthetic leader peptide sequences |
| 12/21/1995 | WO1995034661A1 Fas associated proteins |
| 12/21/1995 | WO1995034655A2 Surface protein of staphylococcus aureus |
| 12/21/1995 | WO1995034654A1 Dna molecules which code for a plastid 2-oxoglutarate/malate translocator |
| 12/21/1995 | WO1995034652A1 Calcium binding recombinant antibody against protein c |
| 12/21/1995 | WO1995034651A2 Corticotropin-releasing factor2 receptors |